Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Scynexis Inc (SCYX)

$1.08 0.04 (3.85%)

16:59 EDT SCYX Stock Quote Delayed 15 Minutes

Volume:

Previous Close $1.08

Market Cap 50.59M

PE Ratio -1.24

EPS -0.87

Volume (Avg. Vol.) 119,300

Day's Range 1.02 - 1.10

52-Week Range 0.35 - 1.90

Dividend & Yield N/A (N/A)

SCYX Stock Predictions, Articles, and Scynexis Inc News

From InvestorPlace
From the Web

5 Healthcare Stocks That Are Down, But Not Out!

By Josh Enomoto, InvestorPlace Contributor Aug 29, 2018

Tough headwinds have impacted several healthcare stocks, presenting opportunities for risk-tolerant speculators.

SCYNEXIS (SCYX) Received its Third Buy in a Row

From Smarter Analyst Aug 12, 2019

After Maxim Group and H.C. Wainwright gave SCYNEXIS (NASDAQ: SCYX) a Buy rating last month, the company received another Buy, this time from Ladenburg

Needham Keeps Their Buy Rating on SCYNEXIS (SCYX)

From Smarter Analyst Aug 12, 2019

In a report issued on August 8, Alan Carr from Needham maintained a Buy rating on SCYNEXIS (SCYX), with a price target of $5. The company's shares closed

Needham Keeps Their Buy Rating on SCYNEXIS (SCYX)

From Analyst Ratings Aug 12, 2019

In a report issued on August 8, Alan Carr from Needham maintained a Buy rating on SCYNEXIS (SCYX – Research Report), with a price target of $5. The company’s shares closed on Friday at $1. According to TipRanks.com, Carr is a 3-star analyst with an average return of 1.8% and a 41.8% success rate. Carr

SCYNEXIS (SCYX) Gets a Buy Rating from Maxim Group

From Smarter Analyst Aug 9, 2019

Maxim Group analyst Jason McCarthy maintained a Buy rating on SCYNEXIS (SCYX) yesterday and set a price target of $4. The company's shares opened today at

Analysts Offer Insights on Healthcare Companies: Aridis Pharmaceuticals Inc (ARDS) and SCYNEXIS (SCYX)

From Smarter Analyst Jul 31, 2019

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aridis Pharmaceuticals Inc (ARDS) and SCYNEXIS (SCYX) with

Analysts Offer Insights on Healthcare Companies: Aridis Pharmaceuticals Inc (NASDAQ: ARDS) and SCYNEXIS (NASDAQ: SCYX)

From Analyst Ratings Jul 31, 2019

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aridis Pharmaceuticals Inc (ARDS – Research Report) and SCYNEXIS (SCYX – Research Report) with bullish sentiments. Aridis Pharmaceuticals Inc (ARDS) In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Aridis Pharmaceuticals

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!